Blog Voices from the Frontlines
Yesterday afternoon, both the House of Representatives and the Senate voted on H.J. Res. 123, a Continuing Resolution that keeps the Government open through December 22, 2017. President Trump signed it into law this morning. H.J. Res 123 continues to fund the Federal Government at existing levels and includes all policy provisions as the previous budget. This includes the Rohrabacher-Blumenauer amendment which is the only thing protecting medical cannabis patients from federal interference and prosecution.
Americans for Safe Access Releases a Blueprint for State Policy
WASHINGTON, DC — Today, Americans for Safe Access released “Medical Cannabis as a Tool to Combat Pain and the Opioid Crisis: A Blueprint for State Policy.” The blueprint outlines legislative and regulatory solutions related to medical cannabis that states can utilize to combat the opioid epidemic.
In the November 2017 Issue:
- Rallies Call for Cannabis Solution to Opioid Crisis
- ASA Files Freedom of Information Requests on Opioid Commission
- ASA Chief Scientist Co-Authors JAMA Study on CBD Product Labeling
- Cannabis Expert Dr. Ethan Russo Joins Center of Excellence
- PFC Trainings, Outreach and Events Span the US
- Activist Profile: Justin Arriola, Utah
- ACTION ALERT: Support the CJS Cannabis Amendment Today!
Kettle Falls Five Matriarch Advocates for CJS Medical Marijuana Amendment in DC - Americans for Safe Access
The last 5 years have been a nightmare for Rhonda Firestack-Harvey, who is well known among medical cannabis advocates as a member of the Kettle Falls Five. For those unfamiliar with the story, Rhonda and her late husband Larry’s property in Washington State, near the town of Kettle Falls was raided in 2012 by the Drug Enforcement Administration (DEA) for growing medical cannabis.
WASHINGTON, DC — On November 9, Americans for Safe Access, filed two requests under the Freedom of Information Act (FOIA) for information on any discussions the Commission had about medical cannabis and specifically the only cannabis study referenced in the President’s Commission on Combating Drug Addiction and the Opioid Crisis draft final report .
By Pat Anson for Pain News Network
“This is a wake up call for the CBD industry to standardize their products,” - Jahan Marcu, PhD
By Amanda MacMillan for Time
“The first step is ordering products from reputable sources or getting advice from other people you trust,” he says, “or getting products tested yourself in an independent lab.” (The group Patient Focused Certification can provide names of nearby facilities that will test CBD extracts, he says.) “Unfortunately, the onus is on the consumer to do the homework.” - Marcel Bonn-Miller, PhD
Medical Marijuana Study: 70 percent of CBD products inaccurately labelled - Americans for Safe Access
Americans for Safe Access Co-Author’s Study in JAMA on Cannabidiol Products
Washington, DC - A new study published this week in JAMA found that nearly 70 percent of all cannabidiol (CBD) products sold online are either over or under labeled, causing potential serious harm to its consumers. The study, co-authored by Jahan Marcu, Ph.D, American’s for Safe Access’ (ASA) Chief Science Officer and Director of Patient Focused Certification (PFC), analyzed 84 CBD products available online from 31 companies.
“This is a wake up call for the CBD industry to standardize their products,” said Dr. Marcu, “CBD product manufacturers need to adopt best practices and accept guidance from AHPA and other groups to improve consistency and safety for consumers. Reaching compliance with existing standards for cannabis-products could help address this issue.”
'A very real danger': U.S. attorney general's views on marijuana create uncertainty over medical cannabis - Americans for Safe Access
By Waqas Chughtai for CBC News
"The prohibition ... is the only thing that limits the [DOJ] from engaging in federal prosecution of patients ... that stops [it] from conducting large-scale raids or bringing federal penalties for a lot of these patients."- David Mangone